<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: kidney cancer</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>New cancer study takes major step toward improved treatment</title>
   	 <description>Cancer researchers at the University of Oklahoma Health Sciences Center have found a way to turn ineffective new cancer drugs into cancer-fighters. By using their patented chemical compound, SHetA2, researchers tricked cancer cells into responding to new treatments and undergoing cell suicide. The research appears in the journal Gynecologic Oncology.</description>
     <link>http://www.physorg.com/news178905949.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Dec 2009 16:06:26 EST</pubDate>
	 <guid isPermaLink="false">news178905949</guid>
</item>
<item>
     <title>FDA questions safety of Glaxo kidney cancer drug</title>
   	 <description>(AP) --  Federal regulators said Thursday an experimental kidney cancer drug from GlaxoSmithKline may cause liver problems, potentially outweighing its ability to slow the disease.</description>
     <link>http://www.physorg.com/news173619012.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 01 Oct 2009 13:00:01 EST</pubDate>
	 <guid isPermaLink="false">news173619012</guid>
</item>
<item>
     <title>Stem cell protein offers a new cancer target</title>
   	 <description>A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.</description>
     <link>http://www.physorg.com/news163081825.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Jun 2009 13:33:06 EST</pubDate>
	 <guid isPermaLink="false">news163081825</guid>
</item>
<item>
     <title>Finding will improve accuracy of cancer diagnosis</title>
   	 <description>  Van Andel Research Institute (VARI) investigators working in collaboration with Cleveland Clinic researchers have determined that two types of kidney tumors previously thought to be different diseases are actually variations of the same disease. This finding will help doctors to more accurately diagnose the disease in patients, and demonstrates the importance of using molecular data to diagnose cancer in general.</description>
     <link>http://www.physorg.com/news160224282.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 29 Apr 2009 11:45:38 EST</pubDate>
	 <guid isPermaLink="false">news160224282</guid>
</item>
<item>
     <title>Does a person's insurance coverage affect their access to quality cancer care?</title>
   	 <description>Does a person's insurance coverage affect their access to quality cancer care? According to researchers at Fox Chase Cancer Center, insurance coverage may not only affect a patient's access to health care, but also the quality of care they receive. Research findings, presented today at the American Urological Association's Annual Meeting, may have implications for a national debate on healthcare reform.</description>
     <link>http://www.physorg.com/news159967460.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 26 Apr 2009 12:24:48 EST</pubDate>
	 <guid isPermaLink="false">news159967460</guid>
</item>
<item>
     <title>Bioengineered proteins: Trial confirms new way to tackle cancer</title>
   	 <description>Re-engineering a protein that helps prevent tumours spreading and growing has created a potentially powerful therapy for people with many different types of cancer. In a study published in the first issue of EMBO Molecular Medicine, Canadian researchers modified the tumour inhibiting protein, von Hippel-Lindau (VHL), and demonstrated that it could suppress tumour growth in mice.</description>
     <link>http://www.physorg.com/news157279849.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 26 Mar 2009 09:51:21 EST</pubDate>
	 <guid isPermaLink="false">news157279849</guid>
</item>
<item>
     <title>Freezing kidney cancer: Hot treatment should be new gold standard for destroying small tumors</title>
   	 <description>Freezing kidney tumors -using a safe minimally invasive interventional radiology treatment that kills the cancer 100 percent effectively without surgery -should be the gold standard or first treatment option for all individuals with tumors that are 4 centimeters in size or smaller. And, this treatment -interventional cryoablation -is a viable option for people with larger tumors, according to two studies presented at the Society of Interventional Radiology's 34th Annual Scientific Meeting.</description>
     <link>http://www.physorg.com/news155814518.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 09 Mar 2009 10:50:00 EST</pubDate>
	 <guid isPermaLink="false">news155814518</guid>
</item>
<item>
     <title>Discovery offers hope for treating kidney cancer</title>
   	 <description>Kidney cancer is typically without symptoms until it has spread to other organs, when it is also the most difficult to treat. Newer chemotherapies show great promise for extending survival during later disease stages, but they can also be highly toxic.</description>
     <link>http://www.physorg.com/news149270404.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 23 Dec 2008 16:00:04 EST</pubDate>
	 <guid isPermaLink="false">news149270404</guid>
</item>
<item>
     <title>UK kidney cancer patients face toxic, out-dated treatments with little hope of change</title>
   	 <description>Leading oncologist Professor Tim Eisen has expressed concerns that patients with advanced kidney cancer could be condemned to toxic, barely effective, 20 year-old treatments because the National Institute for Health and Clinical Excellence (NICE) is likely to rule out using all four of the new treatments it has assessed.</description>
     <link>http://www.physorg.com/news148046546.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 09 Dec 2008 12:02:26 EST</pubDate>
	 <guid isPermaLink="false">news148046546</guid>
</item>
<item>
     <title>Genes associated with fat metabolism could increase kidney cancer risk</title>
   	 <description>A team of international scientists has identified three genes associated with the body's processing of fats that may increase susceptibility to kidney cancer. The findings were presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.</description>
     <link>http://www.physorg.com/news146139216.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 17 Nov 2008 10:13:36 EST</pubDate>
	 <guid isPermaLink="false">news146139216</guid>
</item>
<item>
     <title>Landmark study finds aggresive, personalized treatment increases kidney cancer patient survival</title>
   	 <description>A study of nearly 1,500 patients treated for kidney cancer at UCLA in the last 15 years shows that an aggressive, tailored treatment approach results in better survival rates and uncovered subsets of kidney cancer that behave differently and need to be treated accordingly.</description>
     <link>http://www.physorg.com/news144732836.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 01 Nov 2008 04:33:56 EST</pubDate>
	 <guid isPermaLink="false">news144732836</guid>
</item>
<item>
     <title>Research suggests doctors should consider kidney-sparing surgery</title>
   	 <description>A study of almost 1,500 kidney cancer patients treated at Memorial Sloan Kettering Cancer Center suggests that surgery to spare as much kidney tissue as possible may improve overall survival in patients who also have reduced kidney function at the time their cancer is diagnosed. The finding is significant because both kidney cancer and decreased kidney function appear to be increasing.</description>
     <link>http://www.physorg.com/news142069154.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Oct 2008 08:39:14 EST</pubDate>
	 <guid isPermaLink="false">news142069154</guid>
</item>
<item>
     <title>Researchers find molecule that kills kidney cancer cells</title>
   	 <description>Kidney cancer patients generally have one option for beating their disease: surgery to remove the organ.</description>
     <link>http://www.physorg.com/news134652337.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 07 Jul 2008 12:25:37 EST</pubDate>
	 <guid isPermaLink="false">news134652337</guid>
</item>


</channel>
</rss>

